Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

BACKGROUND AND AIMS:The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatment of hepatitis C was historically challenging. We investigated the safety and ef...

Full description

Bibliographic Details
Published in:Nefrología
Main Authors: Ridruejo, Ezequiel, Garcia Agudo, Rebeca, Mendizabal, Manuel, Aoufi Rabih, Sami, Dixit, Vivek, Silva, Marcelo, Fabrizi, Fabrizio
Format: Article in Journal/Newspaper
Language:English
Published: Sociedad Española de Nefrología Dr Rafael Matesanz
Subjects:
AAD
HCV
CKD
Online Access:http://hdl.handle.net/11336/123087